Assessment of fibroblast growth factor 23 in relation to peripheral arterial disease in type 2 diabetes mellitus
Background Peripheral arterial disease (PAD) is a major vascular complication and the leading cause of amputation in people with diabetes. Fibroblast growth factor 23 (FGF-23) is a recently discovered 30-kD secreted hormone glycoprotein that plays a role in the complex and tightly regulated mechanis...
Main Authors: | Mohamed R Halawa, Abeer A Abdalah, Yara M Eid, Merhan S Nasr, Bassem M Mostafa, Nesma H Ahmed |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-01-01
|
Series: | The Egyptian Journal of Internal Medicine |
Subjects: | |
Online Access: | http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=902;epage=907;aulast=Halawa |
Similar Items
-
Fibroblast growth factor-23 and hypophosphatemia in chronic obstructive pulmonary disease patients
by: Elsammak Mohamed Y., et al.
Published: (2012-01-01) -
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease
by: Mireille El Ters, et al.
Published: (2021-04-01) -
Osteocytic FGF23 and Its Kidney Function
by: Rafiou Agoro, et al.
Published: (2020-08-01) -
Fibroblast Growth Factor 23 is Associated with a Frequent Exacerbator Phenotype in COPD: A Cross-Sectional Pilot Study
by: Swati Gulati, et al.
Published: (2019-05-01) -
Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
by: André Mansinho, et al.
Published: (2019-02-01)